So please continue to share it so that its of use to as many people as possible
Whilst several observational studies and case reports have documented improvements in psoriasis severity among patients treated with GLP-1 medications, these findings require cautious interpretation
Compliance with relevant regulations, including those governing research ethics, subject protection, and controlled substances, is essential
N Engl J Med 392(10):958971 Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, Das S, Lee CJ, Glass LC, Senyucel C, Dunn JP, SURMOUNT-5 Trial Investigators (2025) Tirzepatide as compared with semaglutide for the treatment of obesity
Percentage of Semaglutide Users Reporting Vision Loss or Partial Blindness Study results indicate an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients using semaglutide for Type 2 diabetes and obesity
Chronic kidney disease in heart failure with preserved ejection fraction In the pooled analysis of the SUSTAIN 6 and LEADER trials, with median follow-up periods of 2.1 and 3.8 years respectively, semaglutide and liraglutide demonstrated significant renal benefits compared to placebo
